Oklo Inc. Class A common stock (OKLO)

The sale sounds like a lot, but the CEO still has skin in the game with nearly 472,000 shares owned directly.

There's one thing you must know before you buy Oklo stock.

Oklo posted its first revenue in Q2, with isotope, fuel, and small modular reactor businesses set to ramp through 2028, while a $3 billion cash position eases dilution concerns.

EQNX::TICKER_START (NASDAQ:CEG),(NYSE:SMR),(NYSE:OKLO),(NASDAQ:NNE),(NYSE:BEP) EQNX::TICKER_END

Ai-Driven Electricity Demand Is Creating a Massive New Opportunity for Onsite Generation, Batteries, Microgrids and Energy Infrastructure

It's a bit of a speculative investment right now, but there are encouraging signs.

Oklo just reported its first-ever quarterly revenue.

Uranium Energy and Oklo stand to benefit from powerful tailwinds behind the nuclear energy industry, but only one stock stands out as a better play right now.

Oklo Inc. (NYSE:OKLO) reported Q2 revenue of $1.21 million, beating estimates. 2026 cash flow expected at $120-150 million, shares down 7.7%.

Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project

What does $12 billion of market value buy when combined sales run about $12 million?

Nuclear energy will be a multi-trillion-dollar opportunity.

Groves facility reaches first criticality in under 11 months.

Oklo achieved a crucial milestone.

Oklo Inc. (NYSE: OKLO) (“Oklo” or “the Company”), an advanced nuclear technology company, today published its financial results and business update for the second quarter ended June 30, 2026.

With virtually no revenue line to judge, four things decide this report.

High expectations leave little room for disappointment.

Nuclear investment is still growing, but nuclear share prices have been shrinking.

Supercharge your portfolio with this leading option for nuclear energy industry exposure.

Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today announced that its Groves Isotope Test Reactor has achieved first criticality after achieving a controlled, self-sustaining nuclear chain reaction at low power. The milestone comes less than a year after groundbreaking and follows U.S. Department of Energy (DOE) authorization through the DOE Reactor Pilot Program (RPP).

A positive update on Oklo's reactor progress could reverse the nuclear stock's downward spiral.

Shares of Oklo have fallen close to 40% this year.

From Berkshire Hathaway to Oklo, there are plenty of ways to construct a diversified energy portfolio with $10,000.

Oklo could survive an AI bust, but its valuation probably couldn't.